D
Emergent BioSolutions Inc. EBS
$9.12 -$0.115-1.25% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 851.60M 965.40M 1.04B 1.13B 1.10B
Total Other Revenue -- -- -- -- --
Total Revenue 851.60M 965.40M 1.04B 1.13B 1.10B
Cost of Revenue 370.80M 610.80M 667.60M 716.80M 765.30M
Gross Profit 480.80M 354.60M 376.00M 408.70M 336.90M
SG&A Expenses 233.30M 266.60M 298.70M 327.40M 331.20M
Depreciation & Amortization 65.10M 65.20M 65.10M 65.00M 65.00M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 733.00M 1.01B 1.10B 1.22B 1.27B
Operating Income 118.60M -41.00M -51.60M -89.50M -165.10M
Income Before Tax 190.70M -62.30M -142.90M -169.80M -578.10M
Income Tax Expenses 51.20M 69.30M 47.70M 39.00M 8.90M
Earnings from Continuing Operations 139.50 -131.60 -190.60 -208.80 -587.00
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 139.50M -131.60M -190.60M -208.80M -587.00M
EBIT 118.60M -41.00M -51.60M -89.50M -165.10M
EBITDA 217.40M 62.40M 54.00M 19.50M -54.90M
EPS Basic 2.61 -2.55 -3.63 -4.00 -11.25
Normalized Basic EPS 1.67 -0.33 -1.30 -1.69 -3.02
EPS Diluted 2.45 -2.71 -3.73 -4.11 -11.25
Normalized Diluted EPS 1.57 -0.43 -1.35 -1.73 -3.02
Average Basic Shares Outstanding 215.90M 214.30M 212.10M 209.80M 208.50M
Average Diluted Shares Outstanding 221.30M 219.70M 214.60M 212.30M 208.50M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --